CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

Also called NCT03179800

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Vascular Dynamics, Inc. (from the registry)
Registry
  • NCT NCT03179800
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, France (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03179800. Randomized; triple masking; primary purpose treatment. Start 2017-10-19 (actual); primary completion 2025-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™
Acronym
CALM-2
Condition
Hypertension
Condition
Resistant Hypertension
Intervention (Device)
MobiusHD
Intervention (Other)
Sham Implantation
Lead sponsor
Vascular Dynamics, Inc. (class: industry)

Record details

Record id
cardio:ct-nct03179800
Content hash
0234f7d474e92168b2335067440719f2c1a6ee2fa42be4677b230b21c6636c00